106 related articles for article (PubMed ID: 12571213)
1. 11C-acetate: a new tracer for the evaluation of hepatocellular carcinoma.
Delbeke D; Pinson CW
J Nucl Med; 2003 Feb; 44(2):222-3. PubMed ID: 12571213
[No Abstract] [Full Text] [Related]
2. 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses.
Ho CL; Yu SC; Yeung DW
J Nucl Med; 2003 Feb; 44(2):213-21. PubMed ID: 12571212
[TBL] [Abstract][Full Text] [Related]
3. The importance of acetyl coenzyme A synthetase for 11C-acetate uptake and cell survival in hepatocellular carcinoma.
Yun M; Bang SH; Kim JW; Park JY; Kim KS; Lee JD
J Nucl Med; 2009 Aug; 50(8):1222-8. PubMed ID: 19617323
[TBL] [Abstract][Full Text] [Related]
4. Hepatocelluar carcinoma in an accessory lobe of the liver revealed by 11C-acetate PET with a negative finding on FDG imaging.
Huo L; Dang Y; Feng R; Zhuang H; Li F
Clin Nucl Med; 2012 Apr; 37(4):393-5. PubMed ID: 22391716
[No Abstract] [Full Text] [Related]
5. Clinicopathological presentation of varying 18F-FDG uptake and expression of glucose transporter 1 and hexokinase II in cases of hepatocellular carcinoma and cholangiocellular carcinoma.
Paudyal B; Oriuchi N; Paudyal P; Tsushima Y; Higuchi T; Miyakubo M; Ishikita T; Nakajima T; Endo K
Ann Nucl Med; 2008 Jan; 22(1):83-6. PubMed ID: 18250992
[TBL] [Abstract][Full Text] [Related]
6. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
Ho CL; Chen S; Yeung DW; Cheng TK
J Nucl Med; 2007 Jun; 48(6):902-9. PubMed ID: 17504862
[TBL] [Abstract][Full Text] [Related]
7. A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma.
Park JW; Kim JH; Kim SK; Kang KW; Park KW; Choi JI; Lee WJ; Kim CM; Nam BH
J Nucl Med; 2008 Dec; 49(12):1912-21. PubMed ID: 18997056
[TBL] [Abstract][Full Text] [Related]
8. Tracer kinetic modeling of 11C-acetate applied in the liver with positron emission tomography.
Chen S; Ho C; Feng D; Chi Z
IEEE Trans Med Imaging; 2004 Apr; 23(4):426-32. PubMed ID: 15084068
[TBL] [Abstract][Full Text] [Related]
9. Novel parameter estimation methods for 11C-acetate dual-input liver model with dynamic PET.
Chen S; Feng D
IEEE Trans Biomed Eng; 2006 May; 53(5):967-73. PubMed ID: 16686421
[TBL] [Abstract][Full Text] [Related]
10. Clinical applications and advances of positron emission tomography with fluorine-18-fluorodeoxyglucose (18F-FDG) in the diagnosis of liver neoplasms.
He YX; Guo QY
Postgrad Med J; 2008 May; 84(991):246-51. PubMed ID: 18508981
[TBL] [Abstract][Full Text] [Related]
11. False positive uptake of metaiodobenzylguanidine in hepatocellular carcinoma.
Inoue Y; Akahane M; Kitazawa T; Ijichi H; Obi S; Yoshikawa K; Ohtomo K; Omata M
Br J Radiol; 2002 Jun; 75(894):548-51. PubMed ID: 12124245
[TBL] [Abstract][Full Text] [Related]
12. A concomitant false-negative ¹⁸F-FDG PET imaging in an adrenocortical carcinoma and a high uptake in a corresponding liver metastasis.
Ghander C; Tissier F; Tenenbaum F; Silvera S; Ragazzon B; Bertherat J; Bertagna X; Dousset B; Richard B; Legmann P; Groussin L
J Clin Endocrinol Metab; 2012 Apr; 97(4):1096-7. PubMed ID: 22319030
[No Abstract] [Full Text] [Related]
13. Noninvasive quantification of the differential portal and arterial contribution to the liver blood supply from PET measurements using the 11C-acetate kinetic model.
Chen S; Feng D
IEEE Trans Biomed Eng; 2004 Sep; 51(9):1579-85. PubMed ID: 15376506
[TBL] [Abstract][Full Text] [Related]
14. Technetium-99m sestamibi uptake in hepatocellular carcinoma.
Derebek E
Eur J Nucl Med; 1998 Nov; 25(11):1587-8. PubMed ID: 9882185
[No Abstract] [Full Text] [Related]
15. Different glucose uptake and glycolytic mechanisms between hepatocellular carcinoma and intrahepatic mass-forming cholangiocarcinoma with increased (18)F-FDG uptake.
Lee JD; Yang WI; Park YN; Kim KS; Choi JS; Yun M; Ko D; Kim TS; Cho AE; Kim HM; Han KH; Im SS; Ahn YH; Choi CW; Park JH
J Nucl Med; 2005 Oct; 46(10):1753-9. PubMed ID: 16204727
[TBL] [Abstract][Full Text] [Related]
16. Comparison of (11)C-acetate positron emission tomography and (67)Gallium citrate scintigraphy in patients with hepatocellular carcinoma.
Li S; Beheshti M; Peck-Radosavljevic M; Oezer S; Grumbeck E; Schmid M; Hamilton G; Kapiotis S; Dudczak R; Kletter K
Liver Int; 2006 Oct; 26(8):920-7. PubMed ID: 16953831
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in rat models with hepatocellular carcinoma with liver cirrhosis.
Park SI; Lee JH; Ham HJ; Jung YJ; Park MS; Lee J; Maeng LS; Chung YA; Jang KS
Biomed Mater Eng; 2015; 26 Suppl 1():S1669-76. PubMed ID: 26405933
[TBL] [Abstract][Full Text] [Related]
18. Iso-intense gallium uptake in hepatocellular carcinoma: potential pitfalls in diagnosis.
Lee VW; Staffa M
Nucl Med Commun; 1988 Apr; 9(4):309-15. PubMed ID: 2840616
[TBL] [Abstract][Full Text] [Related]
19. Ga-67-positive and F-18 FDG-negative imaging in well-differentiated hepatocellular carcinoma.
Braga FJ; Flamen P; Mortelmans L; Stroobants S; Homans F; Maes A
Clin Nucl Med; 2001 Jul; 26(7):642. PubMed ID: 11416755
[No Abstract] [Full Text] [Related]
20. Accumulation of 99mTc-PMT in renal metastasis of hepatocellular carcinoma.
Shiozaki T; Hayakawa K; Tanikake M; Oida T; Hida S; Yasui H; Urata Y; Tanaka A; Morimoto T
Ann Nucl Med; 2003 Jun; 17(4):333-6. PubMed ID: 12932119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
